InnerCap Technologies offers Combinaton Capsule Technology

InnerCap Technologies, Inc., a drug delivery company, offers an advanced patent pending multi phased, multi compartmentalized capsular based delivery system. The system can be used to enhance the value and benefits of pharmaceutical and biopharmaceutical products. Utilizing two-piece hard shell capsules, the technology offers the industry solutions to problems affecting pharmaceutical companies, patients and healthcare providers. INNERCAP can fill a companies pipeline with a multitude of combination drug therapies.

The multi-phased, multi-compartmentalized capsular based drug delivery system will be licensed to enhance pharmaceutical and biopharmaceutical products. It is a very effective way to deliver multiple active chemical compounds in different physical phases with controlled release profiles.

This novel delivery system provides the pharmaceutical and biopharmaceutical industries with beneficial solutions to the industry’s highly publicized requirement to repackage and reformulate existing patented blockbuster drugs with expiring patents over the next five years. The delivery system is an exciting solution that will be used by forward looking companies to overcome issues such as life-cycle management, compliance, bioavailability, stability, difficult combination drug therapies, increase their pipeline of products, reduce generic competition, utilize more promising compounds and increase the difficulty in counterfeiting high value products.